223 related articles for article (PubMed ID: 20361937)
1. GPR35 is a novel lysophosphatidic acid receptor.
Oka S; Ota R; Shima M; Yamashita A; Sugiura T
Biochem Biophys Res Commun; 2010 Apr; 395(2):232-7. PubMed ID: 20361937
[TBL] [Abstract][Full Text] [Related]
2. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα₁₃ and β-arrestin-2.
Jenkins L; Alvarez-Curto E; Campbell K; de Munnik S; Canals M; Schlyer S; Milligan G
Br J Pharmacol; 2011 Feb; 162(3):733-48. PubMed ID: 20958291
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons.
Guo J; Williams DJ; Puhl HL; Ikeda SR
J Pharmacol Exp Ther; 2008 Jan; 324(1):342-51. PubMed ID: 17940199
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation.
Resta F; Masi A; Sili M; Laurino A; Moroni F; Mannaioni G
Neuropharmacology; 2016 Sep; 108():136-43. PubMed ID: 27131920
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor 35 contributes to mucosal repair in mice via migration of colonic epithelial cells.
Tsukahara T; Hamouda N; Utsumi D; Matsumoto K; Amagase K; Kato S
Pharmacol Res; 2017 Sep; 123():27-39. PubMed ID: 28648739
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in GPR35 pharmacology; 5-HIAA serotonin metabolite becomes a ligand.
Im DS
Arch Pharm Res; 2023 Jun; 46(6):550-563. PubMed ID: 37227682
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.
Wang J; Simonavicius N; Wu X; Swaminath G; Reagan J; Tian H; Ling L
J Biol Chem; 2006 Aug; 281(31):22021-22028. PubMed ID: 16754668
[TBL] [Abstract][Full Text] [Related]
9. 5-Nitro-2-(3-phenylpropylamino)benzoic acid is a GPR35 agonist.
Taniguchi Y; Tonai-Kachi H; Shinjo K
Pharmacology; 2008; 82(4):245-9. PubMed ID: 18818509
[TBL] [Abstract][Full Text] [Related]
10. GPR35 in Intestinal Diseases: From Risk Gene to Function.
Kaya B; Melhem H; Niess JH
Front Immunol; 2021; 12():717392. PubMed ID: 34790192
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
Zhao P; Sharir H; Kapur A; Cowan A; Geller EB; Adler MW; Seltzman HH; Reggio PH; Heynen-Genel S; Sauer M; Chung TD; Bai Y; Chen W; Caron MG; Barak LS; Abood ME
Mol Pharmacol; 2010 Oct; 78(4):560-8. PubMed ID: 20826425
[TBL] [Abstract][Full Text] [Related]
12. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
Zhao P; Abood ME
Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
14. Crucial positively charged residues for ligand activation of the GPR35 receptor.
Zhao P; Lane TR; Gao HG; Hurst DP; Kotsikorou E; Le L; Brailoiu E; Reggio PH; Abood ME
J Biol Chem; 2014 Feb; 289(6):3625-38. PubMed ID: 24347166
[TBL] [Abstract][Full Text] [Related]
15. MAGI-3 regulates LPA-induced activation of Erk and RhoA.
Zhang H; Wang D; Sun H; Hall RA; Yun CC
Cell Signal; 2007 Feb; 19(2):261-8. PubMed ID: 16904289
[TBL] [Abstract][Full Text] [Related]
16. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Ward Y; Lake R; Yin JJ; Heger CD; Raffeld M; Goldsmith PK; Merino M; Kelly K
Cancer Res; 2011 Dec; 71(23):7301-11. PubMed ID: 21978933
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
[TBL] [Abstract][Full Text] [Related]
18. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.
Tabata K; Baba K; Shiraishi A; Ito M; Fujita N
Biochem Biophys Res Commun; 2007 Nov; 363(3):861-6. PubMed ID: 17905198
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional GPR35 in human iNKT cells.
Fallarini S; Magliulo L; Paoletti T; de Lalla C; Lombardi G
Biochem Biophys Res Commun; 2010 Jul; 398(3):420-5. PubMed ID: 20599711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
